Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment | MicrobiomeTrials← Back to trialsNCT05671718
Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-09-04Est. Completion: 2028-06-30
Enrollment target: 2,944 participants Locations- Doris Goodwin Hospital, Pietermaritzburg, KwaZulu-Natal, South Africa
- Murchison Hospital, Port Shepstone, KwaZulu-Natal, South Africa
- King Dinuzulu TB Hospital, East London, South Africa
- Nkquebela TB Hospital, East London, South Africa
- Jose Pearson Hospital, Port Elizabeth, South Africa
Other microbiome trials you might be interested in
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent TuberculosisTuberculosisExtensively Drug-Resistant Tuberculosis
Background:
\- Tuberculosis (TB) is an infectious disease that affects numerous people worldwide. Researchers are inter…
Bethesda, United States
Rifampicin-Resistant Pulmonary TuberculosisMultidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, ChinaEst. completion Sep 29, 2028